Test Price
2,800 AED✅ Home Collection Available
KCNA1 Gene Episodic Ataxia Type 1 Genetic Test – DHA Licensed Diagnostic in Dubai
Executive Summary & Core Metrics
Premium Genetic Diagnostics in Dubai – 99.9% Sensitivity via ISO 9001:2015 Accredited NGS
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post-test interpretation with Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The KCNA1 NGS test detects pathogenic variants responsible for Episodic Ataxia Type 1, a hereditary channelopathy causing sudden, transient episodes of muscle stiffness and incoordination. This definitive genetic analysis guides neurologists in accurate diagnosis, family screening, and personalised management. Our method provides full gene coverage with superior analytical sensitivity compared to conventional Sanger sequencing.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage including intronic regions | Single‑gene Sanger sequencing, limited to known exonic hotspots |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
| Analytical Sensitivity | >99.9% | 95–98% |
| Regulatory Compliance | DHA Licence 1143, ISO 9001:2015, UAE PDPL | Often not DHA‑listed or ISO‑accredited locally |
Physician Insight & Safety Protocols
"As a consultant in medical genetics, I recognize the significance of precise molecular diagnosis for episodic ataxia type 1. The KCNA1 NGS test provides definitive confirmation, but results must always be contextualised with clinical history and family pedigree. This genetic insight supports tailored management and informed family counselling."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory & Precautionary Measures
Important Medication Caution
Do not discontinue prescribed anti‑epileptic drugs or acetazolamide without consulting your treating physician. Abrupt cessation may precipitate severe ataxic attacks or status epilepticus.
Exclusion Criteria & Safety Red Flags
- Exclusion Criteria: Active febrile illness; pregnancy (requires additional genetic counselling consent); minors without legal guardian consent (Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Emergency Red Flags: If you experience sudden severe ataxia, inability to walk, respiratory distress, or status epilepticus after the test, seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the KCNA1 gene test for episodic ataxia type 1?
This NGS test sequences the entire KCNA1 gene to identify mutations responsible for episodic ataxia type 1, a channelopathy causing sudden, short‑lived episodes of incoordination and muscle stiffness. It provides a definitive molecular diagnosis essential for treatment planning and family screening.
2. How is the sample collected and what is the turnaround time?
We accept a simple blood draw, one drop on an FTA card, or previously extracted DNA sample. Results are delivered in 3 to 4 weeks using ISO‑certified NGS technology with secure online access. Our VIP Mobile Phlebotomy service can collect from your home or office daily between 8 AM and 11 PM.
3. Is this test approved by DHA and covered by insurance?
Yes, our laboratory is licensed by the Dubai Health Authority (License No. 1143) and accredited under ISO 9001:2015. We offer direct insurance billing verification via WhatsApp at +971 54 548 8731 before your appointment.
UAE Regulatory & Data Privacy Adherence
Our laboratory strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields to ensure your genetic data remains confidential, securely stored, and processed only with explicit consent. All results are encrypted and accessible exclusively through your secure patient portal.
Clinical & Logistical Metadata
| Test Name | KCNA1 Gene Episodic Ataxia Type 1 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, FTA Card, or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | G11.2 |
| LOINC Code | 90672-3 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians